Our medications reach more than 740 million people worldwide every year, but many more people still lack access to essential medicines and healthcare. We are committed to helping ensure that our medicines are accessible to as many patients as possible, irrespective of where they come from. We have therefore embarked on a journey to fundamentally shift the way we do business and reimagine how to expand access to critical healthcare innovations.
2017年末, we committed to systematically integrate access strategies into how we research, develop and deliver our new medicines globally and established the 全国十大赌博官网准入原则. These strategies include adopting innovative pricing and access models, refocusing research and 发展 based on society’s healthcare needs, and supporting approaches to strengthen healthcare systems.
